Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Goldfarb, Roy D ^a,c   Parker, Thomas S ^b   Levine, Daniel M ^b   Glock, Dana ^a   Akhter, Imran ^a   Alkhudari, Azzam ^a   McCarthy, Robert J ^a   David, Eric M ^b   Gordon, Bruce R ^b   Saal, Stuart D ^b   Rubin, Albert L ^b   Trenholme, Gordon M ^a   Parrillo, Joseph E ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c University of Medicine and Dentistry   (United States)

Author keywords

Cardiac contractility; Cardiac output; Lipoprotein; Serum endotoxin; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; PHOSPHOLIPID; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CARDIOVASCULAR FUNCTION; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EMULSION; HEART EJECTION FRACTION; HEART OUTPUT; HYPERCHOLESTEROLEMIA; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RISK BENEFIT ANALYSIS; SEPSIS; SWINE;

EID: 0037305705     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00285.2002     Document Type: Article

References (38)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermount G, Carcillo J, and Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
2. 51Cr. J Clin Invest 37: 441-457, 1958.
3. Freudenberg MA, Bog-Hansen TC, Back U, Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 28: 373-380, 1980.
4. Goldfarb RD, Glock D, Johnson K, Creasey AA, Carr C, McCarthy RJ, Matushek M, Akhter I, Trenholme G, and Parrillo JE. Randomized, blinded, placebo controlled trial of tissue factor pathway inhibitor in porcine septic shock. Shock 10: 258-264, 1998.
5. Goldfarb RD, Glock D, Kumar A, McCarthy RJ, Mei J, Guynn T, Matushek M, Trenholme GM, and Parrillo JE. A porcine model of peritonitis and bacteremia simulates human septic shock. Shock 6: 442-451, 1996.
6. Gordon BR, Parker TS, Levine DM, Sall SD, Wang JC, Sloan BJ, Barie PS, Rubin AL. Low lipid levels in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 24: 584-589, 1996.
7. Hamilton RL, Havel RJ, Kane JP, Blaurock AE, and Sata T. Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science 172: 475-478, 1971.
8. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, and Kapp JH. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91: 1028-1034, 1993
9. Hubsch AP, Powell FS, Lerch PG, and Doran JE. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ Shock 40: 14-23, 1993.
10. Iribarren C, Jacobs DR Jr, Sidney S, Claxton AJ, and Feigold KR. Cohort study of serum total cholesterol and inhospital incidence of infectious diseases. Epidemiol Bull Infect 121: 335-347, 1998.
11. Ji Y, Wang N, Ramakrishnan E Sehayek R, Huszar D, Breslow JL, and Tall AR. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 274: 33398-33402, 1999.
12. Kitchens RL, Wolfbauer G, Albers JJ, and Munford RS. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 274: 34116-34122, 1999.
13. Kozarsky KF, Donahee MH, Rigotti SN Iqbal A, Edelman ER, and Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387: 414-417, 1997.
14. Laggner P, Glatter O, Muller K, Kratky O, Kostner G, and Holasek A. The lipid bilayer structure of the abnormal human plasma lipoprotein X. An X-ray small-angle-scattering study. Eur J Biochem 77: 165-171, 1977.
15. Levine DM, Parker TS, Donnelly T, Walsh A, and Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 90: 12040-12044, 1993.
16. Li J, Fang RC, Eisensmith B, Li X, Nasonkin HIC, Lin-Lee YC, Mims M, Hughes A, Montgomery C, Roberts J, Parker TS, Levine DM, and Woo SLC. In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J Clin Invest 95: 768-773, 1995.
17. Musson RA, Morrison DC, and Ulevitch RJ. Distribution of endotoxin (lipopolysaccharide) in the tissues of lipopolysaccharide-responsive and unresponsive mice. Infect Immun 21: 448-457, 1978.
18. National Heart Lung Blood Institute. NHLBI consensus. Conf Circ 86: 1046, 1992.
19. Nichols AV, Krauss RM, and Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 128: 417-431, 1986.
20. Noel MA, Smith TK, and Ettinger WH. Characteristics and outcomes of hospitalized older patients who develop hypocholesterolemia. J Am Geriatr Soc 39: 455-461, 1991.
21. Pajkrt D, Lerch PG, van der Poll T, Levi M, Illi M, Doran JE, Arnet B, Van Den Ende A, Ten Cate JW, and Van Deneter SJ. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb Haemost 77: 303-307, 1997.
22. Pajkrt D, Doran JE, Koster Lerch F, PG, Arnet B, Van Der Poll T, Ten Cate JW, and Van Deventer SJ. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184: 1601-1608, 1996.
23. Parker TS, Levine DM, Chang J, Laxer C, Coffin C, and Rubin AL. Reconstituted high density lipoprotein neutralizes gram negative bacterial lipopolysaccharides in human whole blood. Infect Immun 63: 253-258, 1995.
24. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg MA, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/1OScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
25. Portal I, Clerc T, Sbarra V, Portugal H, Pauli AM, Lafont H, Tuchweber B, Yousef I, and Chanussot F. Importance of high-density lipoprotein-phosphotidylcholine in secretion of phospholipid and cholesterol in bile. Am J Physiol Gastrointest Liver Physiol 264: G1052-G1056, 1993.
26. Read TE, Harris HW, Grunfeld C, Feingold KR, Calhoun MC, Kane JP, and Rapp JH. Chylomicrons enhance endotoxin excretion in bile. Infect Immun 61: 3496-502, 1993.
27. Rensen PCN, van Osten M, van de Bilt E, van Eck M, Kuiper J, and van Berkel TJC. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to parenchymal cells in rats in-vivo. J Clin Invest 99: 2438-2445, 1997.
28. Reuben DB, Ix JH, Greendale GA, and Seeman TE. The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons: MacArthur studies of successful aging. J Am Geriatr Soc Soc. 47: 402-406, 1999.
29. Tall AR, Deckelbaum RJ, Small DM, and Shipley GG. Thermal behavior of human plasma high density lipoprotein. Biochim Biophys Acta 487: 145-153, 1977.
30. Tall AR, Small DM, Shipley GG, and Lees RS. Apoprotein stability and lipid-protein interactions in human plasma high density lipoproteins. Proc Natl Acad Sci USA 72: 4940-4942, 1975.
31. Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, Francone O, and Rubin EM. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 274: 7165-7171, 1999.
32. Ulevitch RJ, Johnston AR, and Weinstein DB. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 64: 1516-1524, 1979.
33. Ulevitch RJ, Johnston AR, and Weinstein DB. New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 67: 827-837, 1981.
34. Verdery RB and Goldberg AP. Hypocholesterolemia as a predictor of death. A prospective study of 224 nursing home residents. J Gerontol A Biol Sci Med Sci 46: M84-90, 1991.
35. Windler E, Ewers-Grabow U, Thiery J, Walli A, Siedel D, and Greten H. The prognostic value of hypocholesterolemia in hospitalized patients. Clin Investig 72: 939-943, 1994.
36. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, and Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990.
37. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, and Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180: 1025-1035, 1994.
38. Yu B, and Wright S D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J Biol Chem 271: 4100-4105, 1996.